In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
 Mark Petrie
Speaker
Mark Petrie
Mark Petrie Mark Petrie

Institute of Cardiovascular and Medical Sciences, University of Glasgow, Clydebank (United Kingdom of Great Britain & Northern Ireland)

Specialities : Chronic Heart Failure , Cardiovascular Surgery, Coronary Artery Disease Chronic

Heart failure, heart failure devices, heart failure interventions, clinical trials and life enthusiast.

16 presentations from this speaker

ESC Webinars Series - Diabetes. Focus 2: SGLT2 Inhibitors - New data and guidelines change practice.

Event : Webinar 2020

  • Session : ESC Webinars 2020
  • Speaker : O Mosenzon (Jerusalem,IL), M Petrie (Glasgow,GB), GMC Rosano (London,GB)

Exploring the link between type 2 diabetes and cardiovascular disease.

Event : ESC Congress 2020

  • Session : The role of glucagon-like peptide-1 receptor agonists in cardiometabolic care
  • Speaker : M Petrie (Glasgow,GB)
  • Sponsored by Novo Nordisk A/S

Panel discussion.

Event : ESC Congress 2020

  • Session : The role of glucagon-like peptide-1 receptor agonists in cardiometabolic care
  • Speaker : M Petrie (Glasgow,GB), S Verma (Toronto,CA), M Kosiborod (Kansas,US)
  • Sponsored by Novo Nordisk A/S

SGLT2 inhibition: Making waves in the heart failure landscape.

Event : HFA Discoveries 2020

  • Session : SGLT2 inhibition: Making waves in the heart failure landscape
  • Speaker : CS Lam (Singapore,SG), J Butler (Atlanta,US), M Petrie (Glasgow,GB), GMC Rosano (London,GB)
  • Organised by CHANGE IME in partnership with Leicester Diabetes Centre

Welcome and introduction.

Event : ESC Congress 2020

  • Session : The role of glucagon-like peptide-1 receptor agonists in cardiometabolic care
  • Speaker : M Petrie (Glasgow,GB)
  • Sponsored by Novo Nordisk A/S

Clinical phenotype and outcomes.

Event : Heart Failure 2019

  • Session : Peripartum cardiomyopathy: new clinical insights
  • Speaker : M Petrie (Glasgow,GB)

How to implement the guidelines.

Event : Heart Failure 2019

  • Session : Guidelines in Daily Practice III: Myocardial revascularisation in heart failure
  • Speaker : M Petrie (Glasgow,GB)

Coronary and valvular interventions

Event : Heart Failure 2018

  • Session : Acute heart failure - When drugs alone are not enough
  • Speaker : M Petrie (Glasgow,GB)

Mitral and tricuspid interventions

Event : Heart Failure 2018

  • Session : Interventional heart failure therapies - Are we there yet?
  • Speaker : M Petrie (Glasgow,GB)

Tricuspid regurgitation

Event : Heart Failure 2018

  • Session : Management of valvular heart disease in heart failure - Drugs, intervention or surgery?
  • Speaker : M Petrie (Glasgow,GB)

STICH – The best revascularisation strategy in ischaemic cardiomyopathy is… ?

Event : Heart Failure 2017

  • Session : How the results of recent randomized clinical trials will impact our practice
  • Speaker : M Petrie (Glasgow,GB)

PCI in heart failure - Putting it all together.

Event : Heart Failure 2016

  • Session : Revascularisation strategies in ischemic heart failure
  • Speaker : M Petrie (Glasgow,GB)

Mechanisms of action and comparative efficacy of the novel vasodilator apelin

Event : Heart Failure 2015

  • Session : Basic Science: Neuroendocrine activation and receptor pharmacology
  • Speaker : M Petrie (Glasgow,GB)

PPCM case

Event : ESC Congress 2015

  • Session : Pregnancy and heart failure
  • Speaker : M Petrie (Glasgow,GB)

Subsequent pregnancy and long-term prognosis.

Event : ESC Congress 2014

  • Session : Update in peripartum cardiomyopathy
  • Speaker : M Petrie (Glasgow,GB)

Risk associated with subsequent pregnancy.

Event : ESC Congress 2013

  • Session : Controversies in peripartum cardiomyopathy
  • Speaker : M Petrie (Glasgow,GB)

Get your access to resources

Join now
  • 1ESC Professional Members – access all ESC Congress resources 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are